Benjamin Warren Purow MD
Neurooncology
Associate Professor, Neurology, University of Virginia School of Medicine
Join to View Full Profile
1240 Lee StCharlottesville, VA 22908
Phone+1 434-924-9333
Fax+1 434-244-7526
Dr. Purow is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 1999 - 2002
Children's National HospitalResidency, Pediatrics, 1996 - 1999- Johns Hopkins University School of MedicineClass of 1996
Certifications & Licensure
VA State Medical License 2006 - 2028
MD State Medical License 1999 - 2015
DC State Medical License 1997 - 2000
American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2013-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2017
Clinical Trials
- RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma Start of enrollment: 2010 May 01
- Stereotactic Radiosurgery With Nivolumab and Valproate in Patients With Recurrent Glioblastoma Start of enrollment: 2016 May 24
Publications & Presentations
PubMed
- Narrowing of glioma vascular caliber via chronic VEGFR2 blockade improves the uniformity of focused ultrasound-mediated small molecule drug delivery.Victoria R Breza, Matthew R Hoch, Claire Huchthausen, Catherine M Gorick, Anna C Debski
Journal of Controlled Release. 2026-06-10 - Microenvironment T-Type calcium channels regulate neuronal and glial processes in tumor cells to promote glioblastoma growth.Collin J Dube, Ying Zhang, Shekhar Saha, Tyler C J Deutsch, Matthew Yorek
Neuro-Oncology. 2026-05-29 - Belzutifan-induced tumor regression in sporadic hemangioblastoma: a case report and literature review.Rebekka E Hooks, Niket Yadav, Mark Willy L Mondia, Georgios Mantziaris, Alaa Saleh
Journal of Neuro-Oncology. 2026-02-14
Journal Articles
- Combined c-met/Trk Inhibition Overcomes Resistance to CDK4/6 Inhibitors in GlioblastomaIchiro Nakano, Benjamin Purow, Clinical Cancer Research
Press Mentions
Ribociclib Shown to Penetrate the Blood-Brain Barrier in GlioblastomaSeptember 13th, 2019
Grant Support
- Novel immunotherapeutic potential of DGKalpha inhibition for glioblastomaUNIVERSITY OF VIRGINIA2022–2027
- Vulnerabilities of MMR-deficient glioblastomaUNIVERSITY OF VIRGINIA2022–2027
- Investigation Of Notch-Inhibiting Micrornas In GliomaNational Cancer Institute2009–2012
- Investigating Alpha-Secretase Inhibitors As Notch Inhibitors &Anti-Glioma AgentsNational Cancer Institute2008–2011
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
